Impact of Emotional Blunting on Patient Social Function and Depressive Symptoms: A Post Hoc Analysis of a Web-Based Survey in Japanese Patients with Major Depressive Disorder
The ODQ subdomains of NC and PR are important factors when evaluating the impact of EB on social function and severity of depressive symptoms in patients with MDD. Physicians should assess EB symptoms for each patient, considering the patient's background.
Authors
- Tatsuya Hoshino (ORCID: https://orcid.org/0000-0002-2357-7000)
- Fumie Tokuda (ORCID: https://orcid.org/0009-0003-0660-7137)
- Jun‐ichi Iga (ORCID: https://orcid.org/0000-0003-4409-3096)
- Yoshiya Moriguchi (ORCID: https://orcid.org/0000-0001-9248-8864)
- Toshiaki Kikuchi (ORCID: https://orcid.org/0000-0003-1025-8796)
- Atsushi Hattori (ORCID: https://orcid.org/0009-0008-1566-536X)
Institutions
- Keio University (JP)
- Ehime University (JP)
- Takeda (Japan) (JP)
Publication Details
- Journal
- Neuropsychiatric Disease and Treatment
- Published
- 2025-04-01
- DOI
- https://doi.org/10.2147/ndt.s485109
- Citations
- 1
- Primary Topic
- Mental Health Research Topics
- Type
- article
- Field-Weighted Citation Impact
- 2.12
Funders
- Eli Lilly and Company
- Sanofi
- Kowa Company
- Mylan
- Boehringer Ingelheim Japan
- Eisai
- Meiji Seika Pharma
- Shionogi
- Ono Pharmaceutical
- H. Lundbeck A/S
- Novartis Pharma
- Japan Society for the Promotion of Science
- Janssen Pharmaceuticals
- Daiichi Sankyo Europe